Insurtech funding rebounds in 2025
Global insurtech funding jumped nearly 20% in 2025, totaling $5.08 billion, reversing a multi-year decline.
The growth was fueled by a few massive deals, including bolttech's $246 million Series C extension and New China Life Insurance's $214 million strategic investment in Pengai. These mega-rounds indicate investor confidence in insurtechs that have demonstrated a clear path to profitability and scalability. Notably, deal volume actually decreased, with 367 deals in 2025 compared to 428 in 2024, suggesting investors are becoming more selective. This trend underscores the increasing pressure on insurtechs to prove their business models and achieve sustainable growth. Late-stage funding rounds experienced a significant boost, while seed-stage funding saw a decline. This shift reflects a maturing market where investors are prioritizing established players over early-stage startups.
